Claims
- 1. A member selected from the group consisting of an N-(4-phenoxy-2-amidophenyl)guanidine compound of the formula: ##STR103## and an N-(5-phenoxy-2-amidophenyl)guanidine of the formula: ##STR104## wherein R.sup.4 is alkyl of 1 to 6 carbon atoms, alkenyl of 2 to 4 carbon atoms, alkynyl of 2 to 4 carbon atoms, cycloalkyl of 3 to 10 carbon atoms, alkoxy of 1 to 6 carbon atoms, phenyl, phenylalkyl of 7 to 12 carbon atoms, alkoxyalkyl of 2 to 12 carbon atoms, phenoxyalkyl of 7 to 12 carbon atoms, amino, alkylamino of 1 to 6 carbon atoms or dialkylamino wherein each alkyl group contains 1 to 6 carbon atoms;
- R.sup.5 is alkyl of 1 to 6 carbon atoms, alkenyl of 2 to 6 carbon atoms or alkynyl of 2 to 6 carbon atoms; and
- R.sup.6 is hydrogen, alkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 10 carbon atoms, alkenyl of 2 to 6 carbon atoms, alkynyl of 2 to 6 carbon atoms, alkoxy of 1 to 6 carbon atoms, alkenyloxy of 2 to 6 carbon atoms, alkynyloxy of 2 to 6 carbon atoms, phenyl, phenylalkyl of 7 to 12 carbon atoms, phenoxyalkyl of 7 to 12 carbon atoms, alkoxyalkyl of 2 to 12 carbon atoms or alkoxyalkoxy of 2 to 12 carbon atoms;
- each of R.sup.2 and R.sup.3 independent of the other is hydrogen, halogeno, alkyl of 1 to 6 carbon atoms, alkoxy of 1 to 6 carbon atoms, alkylthio of 1 to 6 carbon atoms, trifluoromethyl, alkanoyl of 1 to 6 carbon atoms, amino, alkanoylamino of 1 to 6 carbon atoms, or carbalkoxy of 2 to 7 carbon atoms.
- 2. A compound according to claim 1 in which
- R.sup.4 is alkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 7 carbon atoms, alkoxy of 1 to 4 carbon atoms, alkenyl of 2 to 4 carbon atoms, alkynyl of 2 to 4 carbon atoms, alkoxyalkyl of 2 to 8 carbon atoms, phenyl, benzyl or phenethyl;
- R.sup.5 is alkyl of 1 to 4 carbon atoms, alkenyl of 2 to 4 carbon atoms, or alkynyl of 2 to 4 carbon atoms;
- R.sup.6 is hydrogen, alkyl of 1 to 4 carbon atoms, cycloalkyl of 3 to 7 carbon atoms, alkoxy of 1 to 4 carbon atoms, alkenyl of 2 to 4 carbon atoms, alkynyl of 2 to 4 carbon atoms, alkenyloxy of 2 to 4 carbon atoms, alkynyloxy of 2 to 4 carbon atoms, alkoxyalkyl of 2 to 8 carbon atoms, alkoxyalkoxy of 2 to 8 carbon atoms, phenyl, benzyl or phenethyl; and
- each of R.sup.2 and R.sup.3 independent of the other is hydrogen, fluoro, chloro, bromo, alkyl of 1 to 4 carbon atoms, alkoxy of 1 to 4 carbon atoms, alkylthio of 1 to 4 carbon atoms, trifluoromethyl, alkanoyl of 2 to 4 carbon atoms, amino, alkanoylamino of 2 to 4 carbon atoms or carbalkoxy of 2 to 7 carbon atoms.
- 3. A compound according to claim 2 which is an N-(4-phenoxy-2-amidophenyl)guanidine as therein defined.
- 4. A compound according to claim 3 wherein R.sup.4 is alkyl of 1 to 6 carbon atoms or alkoxyalkyl of 2 to 8 carbon atoms, R.sup.5 is alkyl of 1 to 4 carbon atoms, and R.sup.6 is alkoxy of 1 to 4 carbon atoms.
- 5. A compound according to claim 2 which is an N-(5-phenoxy-2-amidophenyl)guanidine as therein defined.
- 6. A compound according to claim 5 wherein R.sup.4 is alkyl of 1 to 6 carbon atoms or alkoxyalkyl of 2 to 8 carbon atoms, R.sup.5 is alkyl of 1 to 4 carbon atoms, and R.sup.6 is alkoxy of 1 to 4 carbon atoms.
- 7. The compound according to claim 1 which has the formula: ##STR105##
- 8. The compound according to claim 1 which has the formula: ##STR106##
- 9. The compound according to claim 1 which has the formula: ##STR107##
- 10. The compound according to claim 1 which has the formula: ##STR108##
- 11. The compound according to claim 1 which has the formula: ##STR109##
- 12. The compound according to claim 1 which has the formula: ##STR110##
- 13. The compound according to claim 1 which has the formula: ##STR111##
- 14. The compound according to claim 1 which has the formula: ##STR112##
- 15. The compound according to claim 1 which has the formula: ##STR113##
- 16. The compound according to claim 1 which has the formula: ##STR114##
- 17. The compound according to claim 1 which has the formula: ##STR115##
- 18. The compound according to claim 1 which has the formula: ##STR116##
- 19. A pharmaceutical composition comprising an anthelmintically effective amount of a compound according to claim 1 and a pharmaceutically acceptable carrier.
- 20. The method of combatting thelmintic infestation in humans and other animals which comprises administering to a human or other animal an anthelmintically effective amount of a compound according to claim 1.
Priority Claims (1)
Number |
Date |
Country |
Kind |
2423679 |
May 1974 |
DT |
|
CROSS-REFERENCE
This is a division of Ser. No. 572,224 filed Apr. 28, 1975, now U.S. Pat. No. 3,993,682.
US Referenced Citations (2)
Number |
Name |
Date |
Kind |
3812173 |
Giraudon |
May 1974 |
|
3869503 |
Widdig et al. |
Mar 1975 |
|
Divisions (1)
|
Number |
Date |
Country |
Parent |
572224 |
Apr 1975 |
|